Related Experiment Video

Updated: Aug 13, 2026

Multifocal Electroretinograms
16:49

Multifocal Electroretinograms

Published on: December 4, 2011

[New trends in progressive multifocal leukoencephalopathy]

J Gasnault1, Y Taoufik

  • 1UF de Suite et Réadaptation, Service de Médecine Interne et des Maladies Infectieuses, Hôpital Universitaire de Bicêtre, APHP, Paris. jacques.gasnault@bct.aphp.fr

Revue Neurologique
|February 1, 2006
PubMed

Insights

JC virus infection causes progressive multifocal leucoencephalopathy (PML), a severe brain disease. Immune system reconstitution improves outcomes for PML patients, with new immunotherapies on the horizon.

Area of Science:

  • Neurovirology
  • Immunology

Context:

  • Progressive multifocal leucoencephalopathy (PML) is a fatal demyelinating disease caused by JC virus lytic infection of oligodendrocytes.
  • PML incidence has risen due to the AIDS pandemic and increased use of immunosuppressive drugs.
  • JC virus reactivation occurs in severe cellular immune deficiency.

Purpose:

  • To review the current understanding of JC virus infection and PML pathogenesis.
  • To discuss the impact of immune reconstitution on PML clinical course.
  • To explore future therapeutic strategies for PML.

Summary:

  • JC virus infection is a model for chronic viral infections managed by the immune system.
  • Highly active antiretroviral therapy has improved PML outcomes in HIV-infected individuals by restoring immune function.
  • Advances in JC virus biology and immune response offer new perspectives for PML management and immunotherapy.

Impact:

  • Reduced one-year mortality for PML in HIV-infected individuals from 90% to approximately 50% due to immune reconstitution.
  • New insights into JC virus pathogenesis and cellular immunity inform patient management.
  • Potential development of novel immunotherapies for PML based on current research trends.

More Related Videos

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients12:23

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients

Published on: April 14, 2014

Related Concept Videos

Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...